PDF) LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug Conjugate | Bioconjugate Chemistry
LXR agonist T0901317 down-regulates the hepatic gluconeogenesis pathway... | Download Scientific Diagram
The effects of LXR agonist T0901317 and LXR antagonist GSK2033 on morphogenesis and lipid properties in full thickness skin models - ScienceDirect
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology
Cancers | Free Full-Text | Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors | HTML
LXR Agonist-treated EOCs Decrease Atherosclerosis | Stem Cells Portal
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink
Liver X Receptor Agonist AZ876 Induces Beneficial Endogenous Cardiac Lipid Reprogramming and Protects Against Isoproterenol‐Induced Cardiac Damage | Journal of the American Heart Association
Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer | Oncogene
Synthetic LXR agonists. | Download Scientific Diagram
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer - ScienceDirect
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH - Cellular and Molecular Gastroenterology and Hepatology
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils - ScienceDirect
Targeting liver X receptors in cancer therapeutics | Nature Reviews Cancer
Screening for liver X receptor modulators: Where are we and for what use? - Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers - ScienceDirect
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression - eBioMedicine
Screening for liver X receptor modulators: Where are we and for what use? - Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library
Frontiers | Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer | Immunology
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink
Liver X receptors in lipid metabolism: opportunities for drug discovery | Nature Reviews Drug Discovery
Effect of LXR agonist on key inflammatory mediators in human pancreatic... | Download Scientific Diagram
Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice* - Journal of Biological Chemistry
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases | SpringerLink
